82 FR 45290 - Submission for OMB Review; Comment Request; Child Care and Development Fund Quality Progress Report
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families Federal Register Volume 82, Issue 187 (September 28, 2017)
Administration for Children and Families
Federal Register Volume 82, Issue 187 (September 28, 2017)
| Page Range | 45290-45291 | |
| FR Document | 2017-20765 |
[Federal Register Volume 82, Number 187 (Thursday, September 28, 2017)] [Notices] [Pages 45290-45291] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-20765] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families [OMB No.: 0970--NEW] Submission for OMB Review; Comment Request; Child Care and Development Fund Quality Progress Report Description: Lead Agencies are required to spend a certain percent of their Child Care and Development Fund (CCDF) awards on activities to improve the quality of child care. Lead Agencies are also required to invest in at least one of 10 allowable quality activities included in the Child Care and Development Block Grant (CCDBG) Act of 2014. In order to ensure that States and Territories are meeting these requirements, the CCDBG Act and the CCDF final rule require Lead Agencies to submit an annual report, identified as the Quality Progress Report in the CCDF final rule. The report must describe how quality funds were expended, including what types of activities were funded and measures used to evaluate progress in improving the quality of child care programs and services. The QPR replaces the Quality Performance Report that was previously an appendix to the CCDF Plan. The QPR increased transparency on quality spending and will continue to gather detailed information on how States and Territories are spending their quality funds, as well as more specific data points to reflect the requirements in the CCDBG Act and the CCDF final rule. In the QPR, Lead Agencies are asked about the State's or Territory's progress in meeting its goals as reported in the CCDF Plan, and provide available data on the results of those activities. Specifically, this report will: (1) Ensure accountability for the use of CCDF quality funds, including a set-aside for quality infant and toddler care that begins in FY 2017; (2) track progress toward meeting State- and Territory-set indicators and benchmarks for improvement of child care quality per what they described in their CCDF Plans; (3) summarize how the Lead Agency is building a progression of professional development for child care providers as envisioned in the CCDBG Act of 2014 and CCDF final rule; and (4) inform federal technical assistance efforts and decisions regarding strategic use of quality funds. The Office of Child Care (OCC) has given thoughtful consideration to the comments received during the 60-day Public Comment Period and has revised the QPR to better align with the new program requirements made under the CCDBG Act of 2014 and the final rule. The revised document also contains additional guidance and clarification where appropriate in order to improve the quality of information that is being collected. Note: A correction was also made to the burden hours. This 30-day Public Comment Period provides an opportunity for the public to submit comments to the Office of Management and Budget (OMB). Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L'Enfant Promenade SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: [email protected]. Respondents: State and Territory CCDF Lead Agencies (56). [[Page 45291]] Annual Burden Estimates ---------------------------------------------------------------------------------------------------------------- Number of Average burden Instrument Number of responses per hours per Total burden respondents respondent response hours ---------------------------------------------------------------------------------------------------------------- CCDF QPR.................................... 56 1 60.0 3,360 ---------------------------------------------------------------------------------------------------------------- Estimated Total Annual Burden Hours: 3,360 hours. Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 330 C Street SW., Washington, DC 20201. Attention Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: [email protected]. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Email: [email protected], Attn: Desk Officer for the Administration for Children and Families. Robert Sargis, Reports Clearance Officer. [FR Doc. 2017-20765 Filed 9-27-17; 8:45 am] BILLING CODE 4184-43-P
![45290 Federal Register / Vol. 82, No. 187 / Thursday, September 28, 2017 / Notices
Commission considers your online and legal basis for the request, and must measures used to evaluate progress in
comment, you must file it at https:// identify the specific portions of the improving the quality of child care
ftcpublic.commentworks.com/ftc/ comment to be withheld from the public programs and services. The QPR
BusinessOpportunityRulePRA_by record. See FTC Rule 4.9(c). Your replaces the Quality Performance Report
following the instructions on the web- comment will be kept confidential only that was previously an appendix to the
based form. When this Notice appears at if the General Counsel grants your CCDF Plan. The QPR increased
http://www.regulations.gov/#!home, you request in accordance with the law and transparency on quality spending and
also may file a comment through that the public interest. Once your comment will continue to gather detailed
Web site. has been posted on the public FTC Web information on how States and
If you file your comment on paper, site—as legally required by FTC Rule Territories are spending their quality
write ‘‘Business Opportunity Rule 4.9(b)—we cannot redact or remove funds, as well as more specific data
Paperwork Comment, FTC File No. your comment from the FTC Web site, points to reflect the requirements in the
P114408’’ on your comment and on the unless you submit a confidentiality CCDBG Act and the CCDF final rule.
envelope, and mail it to the following request that meets the requirements for In the QPR, Lead Agencies are asked
address: Federal Trade Commission, such treatment under FTC Rule 4.9(c), about the State’s or Territory’s progress
Office of the Secretary, 600 and the General Counsel grants that in meeting its goals as reported in the
Pennsylvania Avenue NW., Suite CC– request. CCDF Plan, and provide available data
5610 (Annex J), Washington, DC 20580, The FTC Act and other laws that the
on the results of those activities.
or deliver your comment to the Commission administers permit the
Specifically, this report will: (1) Ensure
following address: Federal Trade collection of public comments to
accountability for the use of CCDF
Commission, Office of the Secretary, consider and use in this proceeding as
quality funds, including a set-aside for
Constitution Center, 400 7th Street SW., appropriate. The Commission will
quality infant and toddler care that
5th Floor, Suite 5610, Washington, DC consider all timely and responsive
begins in FY 2017; (2) track progress
20024. If possible, submit your paper public comments that it receives on or
before November 27, 2017. For toward meeting State- and Territory-set
comment to the Commission by courier indicators and benchmarks for
or overnight service. information on the Commission’s
privacy policy, including routine uses improvement of child care quality per
Because your comment will be placed what they described in their CCDF
on the publicly accessible FTC Web site permitted by the Privacy Act, see
https://www.ftc.gov/site-information/ Plans; (3) summarize how the Lead
at https://www.ftc.gov/, you are solely Agency is building a progression of
responsible for making sure that your privacy-policy.
professional development for child care
comment does not include any sensitive David C. Shonka, providers as envisioned in the CCDBG
or confidential information. In Acting General Counsel. Act of 2014 and CCDF final rule; and (4)
particular, your comment should not [FR Doc. 2017–20846 Filed 9–27–17; 8:45 am] inform federal technical assistance
include any sensitive personal BILLING CODE 6750–01–P efforts and decisions regarding strategic
information, such as your or anyone use of quality funds.
else’s Social Security number; date of
The Office of Child Care (OCC) has
birth; driver’s license number or other
DEPARTMENT OF HEALTH AND given thoughtful consideration to the
state identification number, or foreign
HUMAN SERVICES comments received during the 60-day
country equivalent; passport number;
Public Comment Period and has revised
financial account number; or credit or Administration for Children and the QPR to better align with the new
debit card number. You are also solely Families program requirements made under the
responsible for making sure that your
[OMB No.: 0970—NEW] CCDBG Act of 2014 and the final rule.
comment does not include any sensitive
The revised document also contains
health information, such as medical
Submission for OMB Review; additional guidance and clarification
records or other individually
Comment Request; Child Care and where appropriate in order to improve
identifiable health information. In
Development Fund Quality Progress the quality of information that is being
addition, your comment should not
Report collected. Note: A correction was also
include any ‘‘trade secret or any
made to the burden hours. This 30-day
commercial or financial information Description: Lead Agencies are
Public Comment Period provides an
which . . . is privileged or required to spend a certain percent of
opportunity for the public to submit
confidential’’—as provided by Section their Child Care and Development Fund
comments to the Office of Management
6(f) of the FTC Act, 15 U.S.C. 46(f), and (CCDF) awards on activities to improve
and Budget (OMB).
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— the quality of child care. Lead Agencies
including in particular competitively are also required to invest in at least one Copies of the proposed collection may
sensitive information such as costs, of 10 allowable quality activities be obtained by writing to the
sales statistics, inventories, formulas, included in the Child Care and Administration for Children and
patterns, devices, manufacturing Development Block Grant (CCDBG) Act Families, Office of Administration,
processes, or customer names. of 2014. In order to ensure that States Office of Information Services, 370
Comments containing material for and Territories are meeting these L’Enfant Promenade SW., Washington,
which confidential treatment is requirements, the CCDBG Act and the DC 20447, Attn: ACF Reports Clearance
requested must be filed in paper form, CCDF final rule require Lead Agencies Officer. All requests should be
must be clearly labeled ‘‘Confidential,’’ to submit an annual report, identified as identified by the title of the information
and must comply with FTC Rule 4.9(c). the Quality Progress Report in the CCDF collection. Email address:
In particular, the written request for final rule. The report must describe how infocollection@acf.hhs.gov.
confidential treatment that accompanies quality funds were expended, including Respondents: State and Territory
the comment must include the factual what types of activities were funded and CCDF Lead Agencies (56).
VerDate Sep<11>2014 18:44 Sep 27, 2017 Jkt 241001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\28SEN1.SGM 28SEN1](https://thefederalregister.org/doc/82_FR_45477/page/1.svg)
![Federal Register / Vol. 82, No. 187 / Thursday, September 28, 2017 / Notices 45291
ANNUAL BURDEN ESTIMATES
Number of Average
Number of responses burden Total burden
Instrument respondents per hours per hours
respondent response
CCDF QPR ...................................................................................................... 56 1 60.0 3,360
Estimated Total Annual Burden fees for certain applications for review voucher may be transferred (including
Hours: 3,360 hours. of human drug or biological products by sale) repeatedly until it ultimately is
Additional Information: Copies of the when those applications use a rare used for a human drug application
proposed collection may be obtained by pediatric disease priority review submitted to FDA under section
writing to the Administration for voucher. These vouchers are awarded to 505(b)(1) of the FD&C Act or section
Children and Families, Office of the sponsors of rare pediatric disease 351(a) of the Public Health Service Act.
Planning, Research and Evaluation, 330 product applications that meet all of the A priority review is a review conducted
C Street SW., Washington, DC 20201. requirements of this program and that with a Prescription Drug User Fee Act
Attention Reports Clearance Officer. All are submitted 90 days or more after July (PDUFA) goal date of 6 months after the
requests should be identified by the title 9, 2012, upon FDA approval of such receipt or filing date, depending on the
of the information collection. Email applications. The amount of the fee for type of application. Information
address: infocollection@acf.hhs.gov. using a rare pediatric disease priority regarding PDUFA goals is available at
OMB Comment: OMB is required to review voucher is determined each FY, http://www.fda.gov/downloads/
make a decision concerning the based on the difference between the forindustry/userfees/prescriptiondrug
collection of information between 30 average cost incurred by FDA in the userfee/ucm511438.pdf.
and 60 days after publication of this review of a human drug application The applicant that uses a rare
document in the Federal Register. subject to priority review in the pediatric disease priority review
Therefore, a comment is best assured of previous FY and the average cost voucher is entitled to a priority review
having its full effect if OMB receives it incurred in the review of an application of its eligible human drug application,
within 30 days of publication. Written that is not subject to priority review in but must pay FDA a rare pediatric
comments and recommendations for the the previous FY. This notice establishes disease priority review user fee in
proposed information collection should the rare pediatric disease priority review addition to any user fee required by
be sent directly to the following: Office fee rate for FY 2018 and outlines the PDUFA for the application. Information
of Management and Budget, Paperwork payment procedures for such fees. regarding the rare pediatric disease
Reduction Project, Email: OIRA_ FOR FURTHER INFORMATION CONTACT: priority review voucher program is
SUBMISSION@OMB.EOP.GOV, Attn: Robert J. Marcarelli, Office of Financial available at: http://www.fda.gov/Drugs/
Desk Officer for the Administration for Management, Food and Drug DevelopmentApprovalProcess/
Children and Families. Administration, 8455 Colesville Rd., DevelopmentResources/
COLE–14202F, Silver Spring, MD ucm375479.htm.
Robert Sargis,
20993–0002, 301–796–7223. This notice establishes the rare
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: pediatric disease priority review fee rate
[FR Doc. 2017–20765 Filed 9–27–17; 8:45 am]
for FY 2018 at $2,830,579 and outlines
BILLING CODE 4184–43–P I. Background
FDA’s procedures for payment of rare
Section 908 of FDASIA (Pub. L. 112– pediatric disease priority review user
144) added section 529 to the FD&C Act fees. This rate is effective on October 1,
DEPARTMENT OF HEALTH AND (21 U.S.C. 360ff). In section 529 of the 2017, and will remain in effect through
HUMAN SERVICES FD&C Act, Congress encouraged September 30, 2018.
development of new human drugs and
Food and Drug Administration II. Rare Pediatric Priority Review User
biological products for prevention and
[Docket No. FDA–2017–N–0007] treatment of certain rare pediatric Fee for FY 2018
diseases by offering additional Under section 529(c)(2) of the FD&C
Fee for Using a Rare Pediatric Disease incentives for obtaining FDA approval Act, the amount of the rare pediatric
Priority Review Voucher in Fiscal Year of such products. Under section 529 of disease priority review user fee is
2018 the FD&C Act, the sponsor of an eligible determined each fiscal year based on the
AGENCY: Food and Drug Administration, human drug application submitted 90 difference between the average cost
HHS. days or more after July 9, 2012, for a rare incurred by FDA in the review of a
ACTION: Notice. pediatric disease (as defined in section human drug application subject to
529(a)(3)) shall receive a priority review priority review in the previous fiscal
SUMMARY: The Food and Drug voucher upon approval of the rare year, and the average cost incurred by
Administration (FDA or the Agency) is pediatric disease product application. FDA in the review of a human drug
announcing the fee rate for using a rare The recipient of a rare pediatric disease application that is not subject to priority
pediatric disease priority review priority review voucher may either use review in the previous fiscal year.
voucher for fiscal year (FY) 2018. The the voucher for a future human drug A priority review is a review
Federal Food, Drug, and Cosmetic Act application submitted to FDA under conducted with a PDUFA goal date of 6
(the FD&C Act), as amended by the Food section 505(b)(1) of the FD&C Act (21 months after the receipt or filing date,
and Drug Administration Safety and U.S.C. 355(b)(1)) or section 351(a) of the depending on the type of application.
Innovation Act (FDASIA), authorizes Public Health Service Act (42 U.S.C. Under the PDUFA goals letter, FDA has
FDA to determine and collect rare 262(a)), or transfer (including by sale) committed to reviewing and acting on
pediatric disease priority review user the voucher to another party. The 90 percent of the applications granted
VerDate Sep<11>2014 18:44 Sep 27, 2017 Jkt 241001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\28SEN1.SGM 28SEN1](https://thefederalregister.org/doc/82_FR_45477/page/2.svg)
Document Created: 2017-09-28 01:32:59
Document Modified: 2017-09-28 01:32:59
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 82 FR 45290 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR